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igniﬁcantly different concentrations of cytokines, chemokines and growth factors
healthy and osteoarthritic synovial ﬂuid (average  sd; pg/ml). #p<0.001 and
p<0.05
Healthy
(average 
sd; pg/ml)
OA (average
 sd; pg/ml)
P-value
Eotaxin 22.4  21.4 8.0  18.8 *0.02
G-CSF 90.1  95.4 22.4  15.0 *0.03
IL-6 57.0  112.2 186.1  224.1 #0.001
IP-10 521.5  561.2 1073.6  999.0 #0.001
MDC 55.6  24.4 210.1  87.4 #0.001
MIP-1a 4.5  1.2 16.5  28.2 *0.05
MIP-1ß 12.7  10.6 35.0  44.7 *0.04
PDGF-AA 1.5  3.0 122.6  89.3 #0.001
RANTES 31.7  48.3 762.9  871.9 #0.001
sCD40L 1.0  2.3 29.2  42.3 *0.005
Leptin 837.3  1115 3008.1  3770 *0.01
IL-13 nd 18.1  39.5 *0.01
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S79respectively), that persisted for sHA and uCTX-II after adjustment for age,
gender and BMI (stand betas 0.113, P¼0.003 and 0.129, P¼0.000, respec-
tively). Only cartilage marker combinations showed stronger associations
with baseline summed K&L grades than individual biomarkers (stand beta
0.150, P¼0.000 for uCTX-II+sCOMP+PIIANP+CS846 combination, after
adjustment).
Associations with AUC of the summed K&L score were statistically signif-
icant for uCTX-II, sCOMP, sPIIANP, and sCS846 (stand betas 0.089-0.133,
P<0.018) and persisted after adjustment for age, gender, BMI, and baseline
summed K&L score for sCOMP only (stand beta 0.105, P¼0.005). Stronger
associations were observed for cartilage and synovial combinations (stand
beta 0.128, P¼0.001 for uCTXII+sCOMP+sPIIANP+sCS846, and stand beta
0.110, P¼0.003 for sCOMP+sPIIINP).
Conclusions: Associations with burden and progression of (very) early
knee and hip OAwere observed for cartilage and synovial biomarkers. The
low grade of the associations may be due to limitations of biomarkers as
well as radiography in reﬂecting disease in OA, especially in early-stage
disease. Associations may be stronger at 10-year follow-up and/or when
using more sensitive measures of individual radiographic OA features (e.g.
osteophytes, joint space narrowing, etc). Nevertheless, together with
literature data these results indicate that the search for biomarkers for
(very) early OA should be primarily aimed at (combinations of) cartilage
and synovial metabolism.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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Purpose: The aim of this study is to search for osteoarthritis (OA)
biomarkers in human serum using a novel chemical sequential depletion
method combined with two dimensional difference in-gel electrophoresis
(2D-DIGE) analyses.
Methods: The serum samples were obtained from 20 OA pacientes and 20
non-symptomatic controls. Samples were grouped into four pools of 10
samples each. The pools were subjected to a chemical sequential depletion
protocol involving two precipitation steps, ﬁrst with DTT and then with
ACN, to reduce the high dynamic range of the proteins. Then, the proteo-
mics comparison between OA and control sera was performed across four
DIGE gels. Samples from control and OA pools were labeled with Cy3 or
Cy5 dyes, mixed by pairs and co-resolved by two-dimensional gel elec-
trophoresis using a pool of all samples labeled with Cy2 as internal stan-
dard. The gels were imaged using a DIGE Imager scanner, and quantitative
image analysis was performed using Same Spots software. For protein
identiﬁcation, gel spots were digested by in-gel enzymatic digestion
accelerated with ultrasounds. Then, peptides were analyzed by mass
spectrometry (MALDI-TOF/TOF) and identiﬁed using Mascot with Swis-
sProt knowledgebase. Veriﬁcation of the alteration of SAA and HPT was
performed by immunoblotting.
Results: We report the combination of a novel chemical sequential
depletion method combined with 2D-DIGE for the search of OA
biomarkers. An average of 210 protein spots were detected and matched
on the gel images. The differential analysis resulted in 42 spots signiﬁ-
cantly and reproducibly altered between OA and control samples, 29
increased and 17 decreased. These 45 spots corresponded to 14 different
proteins, many of them related with lipid transport, immune response or
protein binding. We identiﬁed a spot corresponding to a serum amyloid A
protein form (SAA), which was decreased in OA sera when compared to
control. SAA is a major acute phase reactant implicated in the pathogenesis
of rheumatoid arthritis, however, the role of SAA in OA has been poorly
investigated. We also detected two spots corresponding to haptoglobin
precursor (HPT) that exhibited an opposite alteration in OA sera when
compared to control. HPT precursor is an N-linked glycoprotein known to
be cleaved into two chains, alpha and beta, which combine with freeplasma hemoglobin and contribute to the maintenance of cellular iron
homeostasis. Interestingly, HPT beta chain was increased in OA sera whilst
HPT alpha chain was decreased in OA sera when compared to control.
Western blot analyses were performed to conﬁrm these results. The
detection of modulated SAA and HPT protein forms in this work highlight
the usefulness of 2D gel-based approaches for characterizing disease-
speciﬁc patterns of protein modiﬁcations, which are impossible to obtain
from peptide/MS-based proteomic strategies.
Conclusions: We were able to identify 15 protein forms altered in the
disease, corresponding to 14 different proteins. The chemical sequential
depletion coupled to a DIGE-based quantitative proteomic analysis is
useful for protein biomarker discovery. We provide a list of potential OA
biomarker candidates that might be the subject of further validation
studies.
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A DESCRIPTIVE STUDY OF SYNOVIAL FLUID CHANGES IN CYTOKINE,
CHEMOKINE AND GROWTH FACTOR LEVELS BETWEEN
OSTEOARTHRITIS PATIENTS AND HEALTHY DONORS.
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Huizinga 3, G.J. van Osch 4, A.-M. Zuurmond 2. 1UMC Utrecht, Utrecht,
NETHERLANDS; 2 TNO, Leiden, NETHERLANDS; 3 LUMC, Leiden,
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Purpose: Many studies have shown differences between the healthy and
osteoarthritic (OA) joint environment. These studies are mainly based on
a limited set of cytokines, chemokines or growth factors. A comprehensive
proﬁle of these kind of mediators for OA patients could potentially
contribute to the search for new biomarkers or biomarker proﬁles. In the
current study, we analysed 49 soluble mediators in synovial ﬂuid (SF) in
order to examine differences in the healthy and OA joint environment
proﬁle.
Methods: SF was obtained from donors with macroscopically
healthy knee joints (post-mortem material; n¼16) and from OA
patients (total knee arthroplasy for OA; n¼18). All samples were
analyzed for a set of 49 different cytokines, chemokines and growth
factors using multiplex ELISA assays. A non-parametric Mann-Whit-
ney U test was used to determine signiﬁcant differences. Signiﬁcance
was set at p<0.001.
Results: The majority of the soluble mediators could be detected in both
healthy and OA SF. IL-6, IP-10, MDC, PDGF-AA and RANTES were signiﬁ-
cantly increased in OA compared to healthy SF (Table 1.; p<0.001). Leptin,
IL-13, MIP1-a, MIP1-b, sCD-40L were also increased in OA compared to
healthy SF, however less signiﬁcant (p<0.05). In contrast, eotaxin and G-
CSF were decreased in OA synovial ﬂuid (p<0.05). The levels of anabolic
factors such as FGF-2 and TGF-ß were not different between healthy and
OA SF samples.T
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